Cancer Drug Encyclopedia
Approved oncology medications — what they treat, how they work and key safety information.
Prevention and management of chemotherapy-induced and radiation-induced nausea and vomiting (CINV).
Renal Cell Carcinoma (RCC), Hepatocellular Carcinoma (HCC), Thyroid Cancer, Colorectal Cancer, and GIST.
Targeted treatment of solid tumors and hematologic malignancies.
Approved for use in oncology care according to FDA-approved indications.
Adjuvant treatment of operable node-positive Breast Cancer.
Induction chemotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN).
Colorectal, Pancreatic, Breast, Non-Small Cell Lung Cancer, Myelodysplastic Syndromes (MDS), and Acute/Chronic Leukemias.
Advanced solid tumors and hematologic malignancies with matching genomic alterations.
Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Multiple Myeloma.
BRAF V600E/K mutation-positive Melanoma, Non-Small Cell Lung Cancer, Anaplastic Thyroid Cancer, and Colorectal Cancer.
Approved for use in oncology care according to FDA-approved indications.
Adjuvant therapy after tumor resection in patients with NSCLC whose tumors have EGFR exon 19 deletions or exon 21 L858R mutations; first-line treatment for metastatic EGFR-mutated NSCLC; and EGFR T790M mutation-positive metastatic NSCLC.